Growth inhibition of human colorectal-carcinoma cells by interleukin-4 and expression of functional interleukin-4 receptors

This publication has 24 references indexed in Scilit:

• Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation.
  The Journal of Experimental Medicine, 1993
• Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy.
  Journal of Clinical Oncology, 1992
• Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections – a phase I dose toxicity trial
  British Journal of Cancer, 1992
• Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.
  Journal of Clinical Investigation, 1991
• Molecular cloning of a cDNA encoding the human interleukin 4 receptor
  International Immunology, 1990
• Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily.
  The Journal of Experimental Medicine, 1990
• Identification of interleukin 4 receptor‐associated proteins and expression of both high‐ and low‐affinity binding on human lymphoid cells
  European Journal of Immunology, 1989
• Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy?
  British Journal of Cancer, 1989
• B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines.
  The Journal of Experimental Medicine, 1986
• Identification of a T cell-derived b cell growth factor distinct from interleukin 2.
  The Journal of Experimental Medicine, 1982